Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies
European Journal of Cancer Care, 09/11/09
Hong JP et al. – Mucositis of the oral cavity and pharynx is a major dose–limiting factor in the application of radiotherapy (RT) to patients with head and neck cancer. The finding suggests that rhEGF is effective and safe for the treatment of radiation–induced mucositis. Further studies are needed to determine the optimal dosage and fractionation schedule.
Related Articles
Explorative study on the predictive value of systematic inflammatory and metabolic markers on weight loss in head and neck cancer patients undergoing radiotherapy
Supportive Care in Cancer, 10/20/09
Relevance Score: 65%
Effect of topical morphine (mouthwash) on oral pain due to chemotherapy- and/or radiotherapy-induced mucositis: a randomized double-blinded study
Journal of Palliative Medicine, 10/19/09
Relevance Score: 65%
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09
Relevance Score: 64%
Mucositis: The impact, biology and therapeutic opportunities of oral mucositis
Oral Oncology, 10/21/09
Relevance Score: 64%
Informing the debate on oral health care for older people: a qualitative study of older peoples views on oral health and oral health care
Gerodontology, 10/12/09
Relevance Score: 48%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Employment and return to work in head and neck cancer survivors
Oral Oncology , 12/14/09
Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment – An overview
Oral Oncology , 12/14/09
The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins
Clinical Cancer Research, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


